int-2 oncogene amplification and prognosis in node-negative breast carcinoma

Laura Fioravanti, Vera Cappelletti, Danila Coradini, Patrizia Miodini, Giorgio Borsani, Maria Grazia Daidone, Giovanni Di Fronzo

Research output: Contribution to journalArticlepeer-review

Abstract

The role of int-2 oncogene amplification on the prognosis of breast cancer patients was investigated in 128 patients with node-negative primary breast cancers given first-line local-regional treatments until relapse and with a median follow-up of 65 months. Tumours had been previously characterised for oestrogen (ER) and progesterone receptor (PgR) status and proliferative activity (3H-thymidine labelling index). Amplification of the int-2 oncogene occurred in 18% of cases and was significantly related to the presence of hormone receptors and to menopausal status or age, but not to proliferative status. Patients with tumours exhibiting int-2 amplification had a lower probability of disease-free survival than patients with non- amplified tumours and frequently developed local-regional recurrence. Disease-free survival analysis, adjusted for the prognostic contribution provided by tumour size, steroid receptors and proliferative rate, indicated that the association between int-2 amplification and risk of relapse was maintained and remained constant even in the presence of the other co- variates. Interestingly, int-2 amplification was a further prognostic discriminant within subsets of patients with a putatively good (i.e., tumour size + and PgR+) or poor prognosis (i.e., high labelling index). Our exploratory study suggests that within node-negative patients, int-2 amplification could be a valuable and independent prognosticator, useful to identify patients at high risk of local-regional recurrence.

Original languageEnglish
Pages (from-to)620-624
Number of pages5
JournalInternational Journal of Cancer
Volume74
Issue number6
DOIs
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'int-2 oncogene amplification and prognosis in node-negative breast carcinoma'. Together they form a unique fingerprint.

Cite this